Skip to content
1887

Access Microbiology open research platform logo Access Microbiology

Volume 5, Issue 6

Interaction between gut microbiota metabolites and dietary components in lipid metabolism and metabolic diseases Open Access

Abstract

Gut microbiota composition has caused perplexity in developing precision therapy to cure metabolic disorders. However, recent research has focused on using daily diet and natural bioactive compounds to correct gut microbiota dysbiosis and regulate host metabolism. Complex interactions between the gut microbiota and dietary compounds disrupt or integrate the gut barrier and lipid metabolism. In this review, we investigate the role of diet and bioactive natural compounds in gut microbiota dysbiosis and also the modulation of lipid metabolism by their metabolites. Recent studies have revealed that diet, natural compounds and phytochemicals impact significantly on lipid metabolism in animals and humans. These findings suggest that dietary components or natural bioactive compounds have a significant impact on microbial dysbiosis linked to metabolic diseases. The interaction between dietary components or natural bioactive compounds and gut microbiota metabolites can regulate lipid metabolism. Additionally, natural products can shape the gut microbiota and improve barrier integrity by interacting with gut metabolites and their precursors, even in unfavourable conditions, potentially contributing to the alignment of host physiology.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): gut barrier , gut microbiota , lipid metabolism and natural compound
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000403
2023-06-23
2025-01-24
Loading full text...

Full text loading...

/deliver/fulltext/acmi/5/6/acmi000403.html?itemId=/content/journal/acmi/10.1099/acmi.0.000403&mimeType=html&fmt=ahah

References

  1. MetaHIT Consortium Li J, Jia H, Cai X, Zhong H et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32:834–841 [View Article]
     [Google Scholar]
  2. Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC et al. Specialized metabolites from the microbiome in health and disease. Cell Metab 2014; 20:719–730 [View Article] [PubMed]
     [Google Scholar]
  3. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016; 7:189–200 [View Article] [PubMed]
     [Google Scholar]
  4. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L et al. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 2010; 51:1101–1112 [View Article] [PubMed]
     [Google Scholar]
  5. Kindt A, Liebisch G, Clavel T, Haller D, Hörmannsperger G et al. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nat Commun 2018; 9:3760 [View Article] [PubMed]
     [Google Scholar]
  6. Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 2014; 146:1449–1458 [View Article] [PubMed]
     [Google Scholar]
  7. Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract Res Clin Gastroenterol 2013; 27:25–38 [View Article]
     [Google Scholar]
  8. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139:1844–1854 [View Article] [PubMed]
     [Google Scholar]
  9. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517:205–208 [View Article] [PubMed]
     [Google Scholar]
  10. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G et al. Host-gut microbiota metabolic interactions. Science 2012; 336:1262–1267 [View Article] [PubMed]
     [Google Scholar]
  11. Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 535:56–64 [View Article] [PubMed]
     [Google Scholar]
  12. Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J et al. Strains, functions and dynamics in the expanded human microbiome project. Nature 2017; 550:61–66 [View Article]
     [Google Scholar]
  13. Brial F, Le Lay A, Dumas ME, Gauguier D. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases. Cell Mol Life Sci 2018; 75:3977–3990 [View Article] [PubMed]
     [Google Scholar]
  14. Murugesan S, Nirmalkar K, Hoyo-Vadillo C, García-Espitia M, Ramírez-Sánchez D et al. Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis 2018; 37:621–625 [View Article]
     [Google Scholar]
  15. LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S et al. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact 2017; 16:79 [View Article] [PubMed]
     [Google Scholar]
  16. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156:84–96 [View Article] [PubMed]
     [Google Scholar]
  17. Bennett BJ, Vallim TQ de A, Wang Z, Shih DM, Meng Y et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits Complex genetic and dietary regulation. Cell Metabolism 2013; 17:49–60 [View Article]
     [Google Scholar]
  18. Hoyles L, Jiménez-Pranteda ML, Chilloux J, Brial F, Myridakis A et al. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota. Microbiome 2018; 6: [View Article]
     [Google Scholar]
  19. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 2016; 535:376–381 [View Article] [PubMed]
     [Google Scholar]
  20. Parkar SG, Trower TM, Stevenson DE. Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe 2013; 23:12–19 [View Article] [PubMed]
     [Google Scholar]
  21. Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res 2013; 57:523–535 [View Article]
     [Google Scholar]
  22. Dall’Asta M, Calani L, Tedeschi M, Jechiu L, Brighenti F et al. Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 2012; 28:197–203 [View Article]
     [Google Scholar]
  23. Caetano BFR, de Moura NA, Almeida APS, Dias MC, Sivieri K et al. Yacon (Smallanthus sonchifolius) as a food supplement: health-promoting benefits of Fructooligosaccharides. Nutrients 2016; 8:436 [View Article] [PubMed]
     [Google Scholar]
  24. Du W, Xu H, Mei X, Cao X, Gong L et al. Probiotic bacillus enhance the intestinal epithelial cell barrier and immune function of piglets. Benef Microbes 2018; 9:743–754 [View Article] [PubMed]
     [Google Scholar]
  25. Ren Z, Li Y, Liu J, Li H, Li A et al. Coreopsis tinctoria modulates lipid metabolism by decreasing low-density lipoprotein and improving gut microbiota. Cell Physiol Biochem 2018; 48:1060–1074 [View Article]
     [Google Scholar]
  26. Chen D, Yang Z, Chen X, Huang Y, Yin B et al. Effect of Lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet. J Microbiol Biotechnol 2015; 25:687–695 [View Article] [PubMed]
     [Google Scholar]
  27. Uebanso T, Kano S, Yoshimoto A, Naito C, Shimohata T et al. Effects of consuming xylitol on gut microbiota and lipid metabolism in Mice. Nutrients 2017; 9:756 [View Article] [PubMed]
     [Google Scholar]
  28. Li TT, Liu YY, Wan XZ, Huang ZR, Liu B et al. Regulatory efficacy of the polyunsaturated fatty acids from microalgae Spirulina platensis on lipid metabolism and gut microbiota in high-fat diet rats. Int J Mol Sci 2018; 19:3075 [View Article] [PubMed]
     [Google Scholar]
  29. Zhou SM, Wang YQ, Jacoby JJ, Jiang YR, Zhang YQ et al. Effects of medium- and long-chain triacylglycerols on lipid metabolism and gut microbiota composition in C57BL/6J Mice. J Agric Food Chem 2017; 65:6599–6607 [View Article]
     [Google Scholar]
  30. Wan J, Hu S, Jacoby JJ, Liu J, Zhang Y et al. The impact of dietary sn-2 palmitic triacylglycerols in combination with docosahexaenoic acid or arachidonic acid on lipid metabolism and host faecal microbiota composition in Sprague Dawley rats. Food Funct 2017; 8:1793–1802 [View Article]
     [Google Scholar]
  31. Zhou L, Xiao X, Zhang Q, Zheng J, Li M et al. Improved glucose and lipid metabolism in the early life of female offspring by maternal dietary genistein is associated with alterations in the gut microbiota. Front Endocrinol 2018; 9: [View Article]
     [Google Scholar]
  32. Ye J, Lv L, Wu W, Li Y, Shi D et al. Butyrate protects Mice against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol 2018; 9: [View Article]
     [Google Scholar]
  33. Jin Y, Wu Y, Zeng Z, Jin C, Wu S et al. From the cover: exposure to oral antibiotics induces gut microbiota dysbiosis associated with lipid metabolism dysfunction and low-grade inflammation in Mice. Toxicol Sci 2016; 154:140–152 [View Article]
     [Google Scholar]
  34. Jin YX, Zeng ZY, Wu Y, Zhang SB, Fu ZW. Oral exposure of mice to carbendazim induces hepatic lipid metabolism disorder and gut microbiota dysbiosis. Toxicol Sci 2015; 147:116–126 [View Article]
     [Google Scholar]
  35. Yin J, Li Y, Han H, Chen S, Gao J et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice. J Pineal Res 2018; 65:e12524 [View Article] [PubMed]
     [Google Scholar]
  36. Araya-Cloutier C, den Besten HMW, Aisyah S, Gruppen H, Vincken J-P. The position of prenylation of isoflavonoids and stilbenoids from legumes (Fabaceae) modulates the antimicrobial activity against Gram positive pathogens. Food Chem 2017; 226:193–201 [View Article]
     [Google Scholar]
  37. Espley RV, Butts CA, Laing WA, Martell S, Smith H et al. Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. J Nutr 2014; 144:146–154 [View Article] [PubMed]
     [Google Scholar]
  38. Masumoto S, Terao A, Yamamoto Y, Mukai T, Miura T et al. Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes. Sci Rep 2016; 6:31208 [View Article] [PubMed]
     [Google Scholar]
  39. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104 Suppl 2:S1–63 [View Article] [PubMed]
     [Google Scholar]
  40. Valcheva R, Dieleman LA. Prebiotics: definition and protective mechanisms. Best Pract Res Clin Gastroenterol 2016; 30:27–37 [View Article] [PubMed]
     [Google Scholar]
  41. Wang C, Yue S, Hao Z, Ren G, Lu D et al. Pubertal exposure to the endocrine disruptor mono-2-ethylhexyl ester at body burden level caused cholesterol imbalance in mice. Environmental Pollution 2019; 244:657–666 [View Article]
     [Google Scholar]
  42. Yu Y, Liu Q, Li H, Wen C, He Z. Alterations of the gut microbiome associated with the treatment of hyperuricaemia in male rats. Front Microbiol 2018; 9:2233 [View Article] [PubMed]
     [Google Scholar]
  43. Ijaz MU, Ahmed MI, Zou X, Hussain M, Zhang M et al. Beef, casein, and soy proteins differentially affect lipid metabolism, triglycerides accumulation and gut microbiota of high-fat diet-fed C57BL/6J Mice. Front Microbiol 2018; 9:2200 [View Article] [PubMed]
     [Google Scholar]
  44. Li Y, Fu X, Ma X, Geng S, Jiang X et al. Intestinal microbiome-metabolome responses to essential oils in piglets. Front Microbiol 2018; 9:1988 [View Article]
     [Google Scholar]
  45. Alfawaz H, Al-Onazi M, Bukhari SI, Binobead M, Othman N et al. The independent and combined effects of omega-3 and vitamin B12 in ameliorating propionic acid induced biochemical features in juvenile rats as rodent model of autism. J Mol Neurosci 2018; 66:403–413 [View Article] [PubMed]
     [Google Scholar]
  46. Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 2013; 14:660–667 [View Article] [PubMed]
     [Google Scholar]
  47. Pei R, Martin DA, DiMarco DM, Bolling BW. Evidence for the effects of yogurt on gut health and obesity. Crit Rev Food Sci Nutr 2017; 57:1569–1583 [View Article] [PubMed]
     [Google Scholar]
  48. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159–169 [View Article] [PubMed]
     [Google Scholar]
  49. Cani PD. Interactions between gut microbes and host cells control gut barrier and metabolism. Int J Obes Suppl 2016; 6:S28–S31 [View Article] [PubMed]
     [Google Scholar]
  50. Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6:392 [View Article] [PubMed]
     [Google Scholar]
  51. Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM et al. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 2016; 12:133–143 [View Article] [PubMed]
     [Google Scholar]
  52. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci 2013; 110:9066–9071 [View Article] [PubMed]
     [Google Scholar]
  53. Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 2011; 25:2711–2721 [View Article] [PubMed]
     [Google Scholar]
  54. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58:1091–1103 [View Article] [PubMed]
     [Google Scholar]
  55. Birchenough G, Schroeder BO, Bäckhed F, Hansson GC. Dietary destabilisation of the balance between the microbiota and the colonic mucus barrier. Gut Microbes 2019; 10:246–250 [View Article] [PubMed]
     [Google Scholar]
  56. Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I et al. Probiotics in prevention and treatment of obesity: a critical view. Nutr Metab 2016; 13:13 [View Article]
     [Google Scholar]
  57. Roselli M, Devirgiliis C, Zinno P, Guantario B, Finamore A et al. Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr 2017; 12:25 [View Article] [PubMed]
     [Google Scholar]
  58. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M et al. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20:16079–16094 [View Article] [PubMed]
     [Google Scholar]
  59. Roxas JL, Vedantam G, Viswanathan VK. Epithelial maturity influences EPEC-induced desmosomal alterations. Gut Microbes 2019; 10:241–245 [View Article]
     [Google Scholar]
  60. Bai J, Hu Y, Bruner DW. Composition of gut microbiota and its association with body mass index and lifestyle factors in a cohort of 7-18 years old children from the American Gut Project. Pediatr Obes 2019; 14:e12480 [View Article] [PubMed]
     [Google Scholar]
  61. Priyadarshini M, Wicksteed B, Schiltz GE, Gilchrist A, Layden BT. SCFA receptors in pancreatic β cells: novel diabetes targets?. Trends Endocrinol Metab 2016; 27:653–664 [View Article] [PubMed]
     [Google Scholar]
  62. Chambers ES, Morrison DJ, Frost G. Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?. Proc Nutr Soc 2015; 74:328–336 [View Article] [PubMed]
     [Google Scholar]
  63. Clemente-Postigo M, Oliva-Olivera W, Coin-Aragüez L, Ramos-Molina B, Giraldez-Perez RM et al. Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity. Am J Physiol Endocrinol Metab 2019; 316:E319–E332 [View Article] [PubMed]
     [Google Scholar]
  64. Dalby MJ, Aviello G, Ross AW, Walker AW, Barrett P et al. Diet induced obesity is independent of metabolic endotoxemia and TLR4 signalling, but markedly increases hypothalamic expression of the acute phase protein, SerpinA3N. Sci Rep 2018; 8:15648 [View Article] [PubMed]
     [Google Scholar]
  65. Wang Y, Fei Y, Liu L, Xiao Y, Pang Y et al. Polygonatum odoratum polysaccharides modulate gut microbiota and mitigate experimentally induced obesity in rats. Int J Mol Sci 2018; 19:3587 [View Article]
     [Google Scholar]
  66. Moreno-Indias I, Sánchez-Alcoholado L, Pérez-Martínez P, Andrés-Lacueva C, Cardona F et al. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. Food Funct 2016; 7:1775–1787 [View Article] [PubMed]
     [Google Scholar]
  67. Mehrpouya-Bahrami P, Chitrala KN, Ganewatta MS, Tang C, Murphy EA et al. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep 2017; 7:15645 [View Article] [PubMed]
     [Google Scholar]
  68. Qin J, Li Y, Cai Z, Li S, Zhu J et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490:55–60 [View Article] [PubMed]
     [Google Scholar]
  69. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517:205–208 [View Article] [PubMed]
     [Google Scholar]
  70. Reijnders D, Goossens GH, Hermes GDA, Neis EPJG, van der Beek CM et al. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial. Cell Metabolism 2016; 24:63–74 [View Article]
     [Google Scholar]
  71. Henagan TM, Stefanska B, Fang Z, Navard AM, Ye J et al. Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning. Br J Pharmacol 2015; 172:2782–2798 [View Article] [PubMed]
     [Google Scholar]
  72. Lin YC, Chen YT, Hsieh HH, Chen MJ. Effect of Lactobacillus mali APS1 and L. kefiranofaciens M1 on obesity and glucose homeostasis in diet-induced obese mice. J Funct Foods 2016; 23:580–589 [View Article]
     [Google Scholar]
  73. Li C, Li X, Han H, Cui H, Peng M et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized, controlled trials. Medicine 2016; 95:e4088 [View Article] [PubMed]
     [Google Scholar]
  74. Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health. Nat Med 2018; 24:1113–1120 [View Article] [PubMed]
     [Google Scholar]
  75. Collins HL, Drazul-Schrader D, Sulpizio AC, Koster PD, Williamson Y et al. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP. Atherosclerosis 2016; 244:29–37 [View Article] [PubMed]
     [Google Scholar]
  76. Griffin JL, Wang X, Stanley E. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet 2015; 8:187–191 [View Article] [PubMed]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000403
Loading
Interaction between gut microbiota metabolites and dietary components in lipid metabolism and metabolic diseases
Access Microbiology 5, 000403 (2023); https://doi.org/10.1099/acmi.0.000403
/content/journal/acmi/10.1099/acmi.0.000403
/content/journal/acmi/10.1099/acmi.0.000403
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error